https://www.selleckchem.com/pr....oducts/Teniposide(Vu
59, 0.67) for atropine and -1.48 D (- 1.57, -1.39) and 0.77mm (0.73, 0.81) for placebo. Inter-group differences were 0.22 D (95% CI 0.09, 0.35; P 0.001) for SE and - 0.14mm (-0.20, -0.08; P 0.001) for AL. Three patients experienced mild allergic conjunctivitis side effects, with no inter-group difference in incidence (atropine 2.4%; 2/84 patients; placebo 1.4%; 1/84 patients). With good compliance, 0.01% atropine is effective and safe for preventing the progression of childhood myopia. With good compliance, 0.01% atr
Like
Comment
Share
